Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment
2013 ◽
Vol 29
(5)
◽
pp. 369-376
◽
2015 ◽
Vol 62
(3)
◽
pp. 673-680
◽
2014 ◽
Vol 21
(11)
◽
pp. 1183-1196
◽
2014 ◽
Vol 64
(16)
◽
pp. C182
◽
Keyword(s):
2004 ◽
Vol 109
(10)
◽
pp. 1215-1218
◽
2005 ◽
Vol 32
(8)
◽
pp. 999-999
◽